Vivimed Labs Limited (NSE:VIVIMEDLAB)
India · Delayed Price · Currency is INR 6.59
+0.31 (4.94%)
Oct 7, 2026, 3:20 PM IST
Vivimed Labs Market Cap
Vivimed Labs has a market cap or net worth of 546.4 million as of October 7, 2026. That makes Vivimed Labs the world's 44,515th most valuable company and 3,858th in India. Its market cap has increased by 33.13% in one year.
Market Cap
546.40M
Enterprise Value
4.51B
Revenue
763.08M
Global Rank
Country Rank
#3,858 India
PE Ratio
n/a
ChartMarket Cap Chart
Since August 17, 2005, Vivimed Labs's market cap has decreased from 1.04B to 546.40M, a decrease of -47.46%. That is a compound annual growth rate of -3.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 546.40M | -62.71% |
| Dec 31, 2025 | 1.47B | 61.37% |
| Dec 30, 2022 | 907.91M | -49.54% |
| Dec 31, 2021 | 1.80B | 20.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sigachi Industries | 11.22B |
| Bafna Pharmaceuticals | 9.51B |
| Amanta Healthcare | 8.04B |
| Valiant Laboratories | 6.69B |
| Nectar Lifesciences | 2.06B |
| Brooks Laboratories | 1.73B |
| Par Drugs and Chemicals | 1.54B |
| Balaxi Pharmaceuticals | 1.24B |